Press Releases Kane Biotech Inc.

Equities

KNE

CA4838092084

Delayed Toronto S.E. Other stock markets 09:48:30 2024-06-05 am EDT			5-day change	1st Jan Change
0.14 ^CAD	+16.67%		+12.00%	+75.00%

May. 23	Kane Biotech Q1 Loss Widens Despite Revenue Gains; to Report a Q2 Gain Following Sale of STEM Animal Health	MT
May. 23	Kane Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Kane Biotech Announces First Quarter 2024 Financial Results	May. 23	GL
Kane Biotech to Release First Quarter 2024 Financial Results on May 23, 2024	May. 16	AQ
Kane Biotech Expands its Wound Care Portfolio with Patented Schultz Biofilm Wound Map	May. 15	GL
Kane Biotech Expands its Wound Care Portfolio with Patented Schultz Biofilm Wound Map	May. 15	AQ
Kane Biotech to Host Investor Webinar	Apr. 16	GL
Kane Biotech Announces Closing of the Sale of STEM Animal Health to Dechra Veterinary Products	Apr. 15	GL
Canadian Investment Regulatory Organization Trade Resumption - KNE	Apr. 11	AQ
Kane Biotech Announces Agreement in Principle for the Sale of its Interest in STEM Animal Health	Apr. 11	GL
Canadian Investment Regulatory Organization Trading Halt - KNE	Apr. 11	AQ
Kane Biotech Announces Fourth Quarter and Full Year 2023 Financial Results	Mar. 26	GL
Kane Biotech Extends Exclusivity Period on its Offer for its Interest in STEM Animal Health	Mar. 20	GL
Kane Biotech to Release Fourth Quarter and Full Year 2023 Financial Results on March 26, 2024 – Conference Call to Follow	Mar. 19	GL
Kane Biotech to Release Fourth Quarter and Full Year 2023 Financial Results on March 26, 2024 – Conference Call to Follow	Mar. 19	AQ
Kane Biotech Receives Bioscience Association Manitoba Company of the Year Award	Mar. 08	GL
Dr. Robert Huizinga Elected to the Kane Biotech Board and Appointed Executive Chair	Feb. 22	GL
Dr. Robert Huizinga Elected to the Kane Biotech Board and Appointed Executive Chair	Feb. 22	AQ
Kane Biotech Files New Patent on revyve™ Antimicrobial Wound Gel Spray	Jan. 31	GL
Kane Biotech Files New Patent on revyve™ Antimicrobial Wound Gel Spray	Jan. 31	AQ
Kane Biotech to Present its revyve™ Antimicrobial Wound Gel at Boswick Burn and Wound Care Symposium	Jan. 25	GL
Kane Biotech Announces Special Meeting of Shareholders	Jan. 18	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Kane Biotech Inc.

Equities

KNE

CA4838092084

Press Releases

Filters